OrthoAccel Technologies Receives $4,999,975 New Financing
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=77636dec-1a37-4e30-8263-3686161b207f
Date 3/11/2016
Company Name OrthoAccel Technologies
Mailing Address 6575 West Loop South Bellaire, TX 77401 USA
Company Description The AcceleDent System is currently in a randomized controlled clinical trial at the University of Texas Health Science Center in San Antonio. This trial was enrolled under an Investigational Device Exemption.
Proceeds Purposes Proceeds purposes were not disclosed. 11 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.